Literature DB >> 23020294

Pharmacology of iron transport.

Shaina L Byrne1, Divya Krishnamurthy, Marianne Wessling-Resnick.   

Abstract

Elucidating the molecular basis for the regulation of iron uptake, storage, and distribution is necessary to understand iron homeostasis. Pharmacological tools are emerging to identify and distinguish among different iron transport pathways. Stimulatory or inhibitory small molecules with effects on iron uptake can help characterize the mechanistic elements of iron transport and the roles of the transporters involved in these processes. In particular, iron chelators can serve as potential pharmacological tools to alleviate diseases of iron overload. This review focuses on the pharmacology of iron transport, introducing iron transport membrane proteins and known inhibitors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23020294      PMCID: PMC3837343          DOI: 10.1146/annurev-pharmtox-010611-134648

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  173 in total

1.  Bleomycin-detectable iron in knee-joint synovial fluid from arthritic patients and its relationship to the extracellular antioxidant activities of caeruloplasmin, transferrin and lactoferrin.

Authors:  J M Gutteridge
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

2.  ZRT/IRT-like protein 14 (ZIP14) promotes the cellular assimilation of iron from transferrin.

Authors:  Ningning Zhao; Junwei Gao; Caroline A Enns; Mitchell D Knutson
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

Review 3.  Iron transport.

Authors:  M Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2000       Impact factor: 11.848

4.  Manganese metabolism is impaired in the Belgrade laboratory rat.

Authors:  A C Chua; E H Morgan
Journal:  J Comp Physiol B       Date:  1997-07       Impact factor: 2.200

5.  Antitumor activity and mechanism of action of the iron chelator, Dp44mT, against leukemic cells.

Authors:  Egarit Noulsri; Des R Richardson; Surada Lerdwana; Suthat Fucharoen; Tetsuo Yamagishi; Danuta S Kalinowski; Kovit Pattanapanyasat
Journal:  Am J Hematol       Date:  2009-03       Impact factor: 10.047

6.  Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload.

Authors:  Martha P Mims; Yongli Guan; Dagmar Pospisilova; Monika Priwitzerova; Karel Indrak; Prem Ponka; Vladimir Divoky; Josef T Prchal
Journal:  Blood       Date:  2004-09-30       Impact factor: 22.113

7.  Novel "hybrid" iron chelators derived from aroylhydrazones and thiosemicarbazones demonstrate selective antiproliferative activity against tumor cells.

Authors:  David B Lovejoy; Des R Richardson
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

8.  Phase II study of Triapine in patients with metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161).

Authors:  Jennifer J Knox; Sebastien J Hotte; Christian Kollmannsberger; Eric Winquist; Bryn Fisher; Elizabeth A Eisenhauer
Journal:  Invest New Drugs       Date:  2007-03-28       Impact factor: 3.850

9.  Chemical genetic screening identifies sulfonamides that raise organellar pH and interfere with membrane traffic.

Authors:  Thomas J F Nieland; Yan Feng; Jing Xu Brown; Tuan Daniel Chuang; Peter D Buckett; Jin Wang; Xiao-Song Xie; Timothy E McGraw; Tomas Kirchhausen; Marianne Wessling-Resnick
Journal:  Traffic       Date:  2004-07       Impact factor: 6.215

Review 10.  Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas.

Authors:  Michael Weaver; Douglas W Laske
Journal:  J Neurooncol       Date:  2003-10       Impact factor: 4.130

View more
  10 in total

Review 1.  Direct Cell Radiolabeling for in Vivo Cell Tracking with PET and SPECT Imaging.

Authors:  Peter J Gawne; Francis Man; Philip J Blower; Rafael T M de Rosales
Journal:  Chem Rev       Date:  2022-05-12       Impact factor: 72.087

2.  Iron loading impairs lipoprotein lipase activity and promotes hypertriglyceridemia.

Authors:  Jonghan Kim; Xuming Jia; Peter D Buckett; Sihao Liu; Chih-Hao Lee; Marianne Wessling-Resnick
Journal:  FASEB J       Date:  2012-12-14       Impact factor: 5.191

3.  A Radio-Nano-Platform for T1/T2 Dual-Mode PET-MR Imaging.

Authors:  Yaser Hadi Gholami; Hushan Yuan; Moses Q Wilks; Richard Maschmeyer; Marc D Normandin; Lee Josephson; Georges El Fakhri; Zdenka Kuncic
Journal:  Int J Nanomedicine       Date:  2020-02-24

4.  T1- and T2-weighted Magnetic Resonance Dual Contrast by Single Core Truncated Cubic Iron Oxide Nanoparticles with Abrupt Cellular Internalization and Immune Evasion.

Authors:  Bibek Thapa; Daysi Diaz-Diestra; Carlene Santiago-Medina; Nitu Kumar; Kaixiong Tu; Juan Beltran-Huarac; Wojciech M Jadwisienczak; Brad R Weiner; Gerardo Morell
Journal:  ACS Appl Bio Mater       Date:  2018-06-15

5.  Repurposing ICG enables MR/PA imaging signal amplification and iron depletion for iron-overload disorders.

Authors:  Huirong Lin; Yu Zhou; Jiaming Wang; Huimeng Wang; Tianhong Yao; Hu Chen; Huili Zheng; Yang Zhang; En Ren; Lai Jiang; Chengchao Chu; Xiaoyuan Chen; Jingsong Mao; Fudi Wang; Gang Liu
Journal:  Sci Adv       Date:  2021-12-17       Impact factor: 14.136

6.  New Insights into the Pivotal Role of Iron/Heme Metabolism in TLR4/NF-κB Signaling-Mediated Inflammatory Responses in Human Monocytes.

Authors:  Dong Young Kang; Nipin Sp; Eun Seong Jo; Jin-Moo Lee; Kyoung-Jin Jang
Journal:  Cells       Date:  2021-09-27       Impact factor: 6.600

7.  Shotgun and TMT-Labeled Proteomic Analysis of the Ovarian Proteins of an Insect Vector, Aedes aegypti (Diptera: Culicidae).

Authors:  Dawn L Geiser; Wenzhou Li; Daphne Q-D Pham; Vicki H Wysocki; Joy J Winzerling
Journal:  J Insect Sci       Date:  2022-03-01       Impact factor: 1.857

8.  Computational Modeling of Macrophage Iron Sequestration during Host Defense against Aspergillus.

Authors:  Borna Mehrad; Reinhard Laubenbacher; Bandita Adhikari; Yogesh Scindia; Luis Sordo Vieira; Henrique de Assis Lopes Ribeiro; Joseph Masison; Ning Yang; Luis L Fonseca; Matthew Wheeler; Adam C Knapp; Yu Mei; Brian Helba; Carl Atkinson; Will Schroeder
Journal:  mSphere       Date:  2022-07-12       Impact factor: 5.029

9.  Ferristatin II promotes degradation of transferrin receptor-1 in vitro and in vivo.

Authors:  Shaina L Byrne; Peter D Buckett; Jonghan Kim; Flora Luo; Jack Sanford; Juxing Chen; Caroline Enns; Marianne Wessling-Resnick
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

10.  Neutrophil gelatinase-associated lipocalin increases HLA-G(+)/FoxP3(+) T-regulatory cell population in an in vitro model of PBMC.

Authors:  Gaetano La Manna; Giulia Ghinatti; Pier Luigi Tazzari; Francesco Alviano; Francesca Ricci; Irene Capelli; Vania Cuna; Paola Todeschini; Eugenio Brunocilla; Pasqualepaolo Pagliaro; Laura Bonsi; Sergio Stefoni
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.